Update on the sexual impact of treatment for benign prostatic hyperplasia

John Roger Bell; Eric Laborde

doi:10.1007/s11934-012-0278-5

Update on the sexual impact of treatment for benign prostatic hyperplasia

Curr Urol Rep. 2012 Dec;13(6):433-40. doi: 10.1007/s11934-012-0278-5.

Authors

John Roger Bell¹, Eric Laborde

Affiliation

¹ Department of Urology, Ochsner Clinic Foundation, New Orleans, LA 70121, USA. jbell@ochsner.org

PMID: 23065462
DOI: 10.1007/s11934-012-0278-5

Abstract

There is an established link between lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). The medical and surgical management of LUTS can affect erectile function (EF), cause ejaculatory dysfunction (EjD) or affect libido. This article will review the effects of these therapies on sexual function.

Publication types

Review

MeSH terms

5-alpha Reductase Inhibitors / adverse effects
Adrenergic alpha-1 Receptor Antagonists / adverse effects
Erectile Dysfunction / etiology*
Humans
Libido*
Male
Phosphodiesterase 5 Inhibitors / adverse effects
Prostatectomy / adverse effects
Prostatectomy / methods
Prostatic Hyperplasia / therapy*

Substances

5-alpha Reductase Inhibitors
Adrenergic alpha-1 Receptor Antagonists
Phosphodiesterase 5 Inhibitors